Information and Awareness Newsletter – January 2025

Information and Awareness Newsletter – January 2025

Information and Awareness Newsletter January Edition Welcome to the first edition of the Information and Awareness Newsletter for 2025! Hear from the team at Huntington’s Victoria on some of their favourite moments of 2024, and take a sneak peak at the events to...
Sage Therapeutics Clinical Trial Update

Sage Therapeutics Clinical Trial Update

Clinical Trial Update: Sage Therapeutics Sage Therapeutics Discontinue Dalzanemdor Trial   We are saddened to share that the clinical trial for dalzanemdor, a drug aimed at improving cognitive challenges for people with Huntington’s disease, has been...